⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma

Official Title: A Phase 2, Multicenter, Open-label, Single Arm Study of Lenalidomide (CC-5013) in Combination With Low-dose Dexamethasone in Japanese Patients With Previously Untreated Multiple Myeloma

Study ID: NCT01698801

Study Description

Brief Summary: To determine the efficacy of lenalidomide in combination with low-dose dexamethasone in Japanese subjects with previously untreated multiple myeloma.

Detailed Description:

Eligibility

Minimum Age: 20 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan

Nagoya City University Hospital, Nagoya, Aichi, Japan

Kameda Medical Center, Kamogawa, Chiba, Japan

Japanese Red Cross Narita Hospital, Narita, Chiba, Japan

Ehime University Hospital, Touon, Ehime, Japan

Nishigunma National Hospital, Shibukawa, Gunma, Japan

Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan

Hitachi General Hospital, Hitachi, Ibaraki, Japan

Iwate Medical University, Morioka, Iwate, Japan

Tokai University Hospital, Isehara, Kanagawa, Japan

Tohoku University Hospital, Sendai, Miyagi, Japan

Kurashiki Central Hospital, Kurashiki, Okayama, Japan

Kinki University Hospital, Faculty of Medicine, Osakasayama, Osaka, Japan

Shizuoka Cancer Center, Sunto, Shizuoka, Japan

National Disaster Medical Center, Tachikawa, Tokyo, Japan

Kagoshima Medical Center, Kagoshima, , Japan

University Hospital, Kyoto Prefectural University of Medicine, Kyoto, , Japan

Niigata Cancer Center Hospital, Niigata, , Japan

Okayama Medical Center, Okayama, , Japan

Osaka Red Cross Hospital, Osaka, , Japan

National Cancer Center Hospital, Tokyo, , Japan

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, , Japan

Japanese Red Cross Medical Center, Tokyo, , Japan

Keio University Hospital, Tokyo, , Japan

Contact Details

Name: Toru Sasaki

Affiliation: Celgene K.K.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: